Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
22 Leser
Artikel bewerten:
(0)

Mindray Medical International Limited Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting

SHENZHEN, China, Dec. 18 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 15, 2009.

At the meeting, Mindray Medical International's shareholders approved the re-election of directors Mr. Xu Hang, Mr. Chen Qingtai, and Mr. Ronald Ede, each to serve a three-year term.

Mindray shareholders also ratified the appointment of PricewaterhouseCoopers as the company's independent registered public accounting firm for the 2008 and 2009 fiscal years.

Additionally, Mindray shareholders approved an amendment to increase by 6,000,000 the number of shares that may be delivered pursuant to awards granted under the Company's 2006 Employee Share Incentive Plan; the new share limit shall be 21,000,000.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com/ .

For investor and media inquiries please contact: In the U.S.: Evan Smith, CFA FD Tel: +1-212-850-5606 Email: evan.smith@fd.com John Capodanno FD Tel: +1-212-850-5705 Email: john.capodanno@fd.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: cathy.gao@mindray.com

Mindray Medical International Limited

CONTACT: In the U.S. - Evan Smith, CFA of FD, +1-212-850-5606, or
evan.smith@fd.com; John Capodanno of FD, +1-212-850-5705, or
john.capodanno@fd.com; In China - Cathy Gao, +86-755-2658-2518, or
cathy.gao@mindray.com

Web Site: http://ir.mindray.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.